← Back to Search

CRxD Caregiver Support for Dementia (CRx-D Trial)

N/A

Waitlist Available

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Has access to a cell phone and provides the research interviewer with the cell phone number

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 7 days, 30 days, 90 days, 12 months

Awards & highlights

CRx-D Trial Summary

This trial will test whether the CRx-C intervention, which includes counseling and support groups, can help caregivers of people with Alzheimer's Disease and related dementias who have unmet health-related social needs.

Who is the study for?

This trial is for caregivers living in specific zip codes who look after someone at home with Alzheimer's or related dementias. They must have a cell phone, agree to text messages from the study, and have an email address. An additional group of male or trans male/trans man caregivers will be included.Check my eligibility

What is being tested?

The trial tests if providing CRx-D resources to caregivers improves their confidence in caring for people with dementia compared to usual care. Caregivers are randomly chosen to receive either the CRx-D intervention or continue with their regular support routines.See study design

What are the potential side effects?

Since this trial involves caregiver resources rather than medical treatments, there are no direct physical side effects expected from participating in this study.

CRx-D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a cell phone and can share its number for research purposes.

CRx-D Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 7 days, 30 days, 90 days, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 7 days, 30 days, 90 days, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 7 days, 30 days, 90 days, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline in caregiver self-efficacy

CRx-D Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CasesExperimental Treatment1 Intervention

Community Rx-Dementia "CRxD" Caregiver Resources

Group II: ControlActive Control1 Intervention

Usual Standard Care

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor

1,003 Previous Clinical Trials

819,385 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,016,699 Total Patients Enrolled

Media Library

Community Rx-Caregiver Resources Clinical Trial Eligibility Overview. Trial Name: NCT04146545 — N/A

Health Related Social Needs Research Study Groups: Control, Cases

Health Related Social Needs Clinical Trial 2023: Community Rx-Caregiver Resources Highlights & Side Effects. Trial Name: NCT04146545 — N/A

Community Rx-Caregiver Resources 2023 Treatment Timeline for Medical Study. Trial Name: NCT04146545 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available in this clinical experiment?

"According to the information provided on clinicaltrials.gov, this particular investigation is no longer seeking participants; it was initially published in December 16th 2019 and last modified on September 27 2022. However, 401 other trials currently require subjects for their research studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CommunityRx-Dementia

2019. "CommunityRx-Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04146545.